A Phase 1b Study of BYL719 (alpelisib) in Combination with Androgen Receptor Inhibitor (enzalutamide) in Patients with Androgen Receptor (Ar)-Positive and PTEN-positive Metastatic Breast Cancer
Cancer Research（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined